Today: 22 July 2026
General Dynamics stock forecast after Iran strikes: what GD investors watch ahead of Monday’s open
28 February 2026
2 mins read

General Dynamics stock forecast after Iran strikes: what GD investors watch ahead of Monday’s open

NEW YORK, Feb 28, 2026, 15:55 EST — Market has closed.

  • Saturday saw the U.S. and Israel striking targets in Iran, while Iran answered with missile launches aimed at Israel and Gulf states where U.S. bases are located.
  • General Dynamics finished Friday at $357.05, climbing 1.8% just before a weekend with potential to shift risk sentiment.
  • Defense stocks could see a short-lived bump from an Iran strike, Bernstein analysts said. For sustained upside, though, it typically takes either more spending or a drawn-out campaign.

General Dynamics could see heightened attention as U.S. markets reopen Monday, following coordinated U.S. and Israeli strikes on Iran that rattled oil prices and stoked concerns of broader conflict. Israel claimed Supreme Leader Ayatollah Ali Khamenei was killed during the assault, though Reuters was unable to independently verify the report.

Energy and shipping are front and center as markets brace for potential fallout. Reuters flagged that some oil majors and trading firms have hit pause on crude and fuel shipments through the Strait of Hormuz. Middle East bourses kick off trading on Sunday, giving investors an early read on sentiment. “I suspect markets will be down if these hostilities continue through the day,” said Ryan Lemand, CEO and co-founder of Neovision Wealth Management. Reuters

The real test for U.S. stocks comes Monday: will investors pull back, shifting funds out of equities and into safe harbors such as cash, Treasuries, or gold? “This geopolitical uncertainty will further catalyse a rise in gold,” said Priyanka Kishore, founder of Asia Decoded. Reuters

General Dynamics ended Friday at $357.05, marking a 1.8% gain. Over the last year, the stock’s range has stretched from $239.20 up to $369.70, Investing.com data show.

Lockheed Martin finished up 2.56% at $658.08, RTX climbed 2.52% to $202.62, and Northrop Grumman tacked on 1.90% to $724.38 in the latest session. All three outperformed as the S&P 500 edged lower.

General Dynamics straddles a range of sectors: business jets, submarines, land vehicles, and IT services. When volatility hits, those pieces can tug the company in different directions. The business breaks down into four segments: Aerospace, Marine Systems, Combat Systems, and Technologies.

Right before the weekend, the company secured new Pentagon-related deals. In the U.S. Department of War’s daily contracts update, General Dynamics Mission Systems showed up with a Navy contract action—capped at $36.15 million—covering fire-control work for the Sea-Launched Cruise Missile program, which is nuclear-armed. Another line item: General Dynamics Electric Boat, picking up about $45.0 million for Virginia-class submarine parts and materials.

Even so, a few analysts warn it’s not a given that a single strike leads to lasting gains for defense stocks. Bernstein’s Douglas Harned and Adrien Rabier, commenting on the Iran situation, put it this way: “An attack may result in short-term upside for the stocks, but, more would be required for sustained upside.” Investing.com

When it comes to valuation, analysts still tie their “forecast” to official price targets. For General Dynamics, the average 12-month target lands at $394.53, with individual estimates spanning from $327.00 on the low end up to $444.00, Investing.com data shows. Investing.com

Earnings marked the most recent major catalyst. General Dynamics, back in late January, topped Wall Street profit and revenue forecasts for the quarter, yet its full-year adjusted profit outlook came in under consensus. The company cited cost pressures and execution challenges heading into 2026.

Risks are not limited to geopolitics. In Washington, a Trump-era executive order now threatens defense contractors’ shareholder payouts if the Pentagon finds delivery timelines slipping. Reuters reported the Pentagon is putting together a list of affected firms, giving them just 15 days to respond with remediation plans.

General Dynamics stock faces a straightforward, if tangled, near-term scenario. A Monday rally for defense shares might run out of steam should a wider market drop hit on surging oil or geopolitical tension. On the flip side, any de-escalation headlines could quickly erase the “war premium” baked into these trades.

Sunday night’s U.S. futures and the March 2 Monday cash open are set to give investors their first real look at how defense stocks might react, with attention on the latest from the Strait of Hormuz and any official word out of Washington about the conflict’s direction.

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation. Follow Marcin Frąckiewicz on Google News, Facebook. or Linkedin.

Stock Market Today

  • ALPS Disruptive Technologies ETF (DTEC) Slips Under 200 Day Moving Average
    July 22, 2026, 4:37 PM EDT. The ALPS Disruptive Technologies ETF (DTEC) declined below its 200 day moving average of $47.84 on Wednesday, reaching a session low of $47.73. DTEC is currently off roughly 1.2% for the day. In the last year, DTEC has traded between $41.99 and $52.97, with the current price hovering near its moving average.
Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears
Previous Story

Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Next Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

Go toTop